Federal Register / Vol. 80, No. 32 / Wednesday, February 18, 2015 / Notices 8661 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control; Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Public Health Research on 

Modifiable Risk Factors for Spina 

Bifida, DD15–001, initial review. 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 10:00 a.m.–6:00 p.m., 

March 19, 2015 (Closed) 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in section 552b(c) 

(4) and (6), title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Pub. L. 92–463. 

Matters for Discussion: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Public Health Research on Modifiable 

Risk Factors for Spina Bifida, DD15– 

001, initial review.’’ 

Contact Person for More Information: 

M. Chris Langub, Ph.D., Scientific 

Review Officer, CDC, 4770 Buford 

Highway NE., Mailstop F–80, Atlanta, 

Georgia 30341, Telephone: (770) 488– 

3585, EEO6@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–03254 Filed 2–17–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Comparison and Validation of 

Screening Tools for Substance Use 

Among Pregnant Women, DP15–003, 

initial review. 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date 

9:00 a.m.–6:30 p.m., March 18, 2015 

(Closed) 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in section 552b(c) 

(4) and (6), title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Pub. L. 92–463. 

Matters for Discussion: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Comparison and Validation of 

Screening Tools for Substance Use 

among Pregnant Women, DP15–003, 

initial review.’’ 

Contact Person for More Information: 

M. Chris Langub, Ph.D., Scientific 

Review Officer, CDC, 4770 Buford 

Highway NE., Mailstop F–80, Atlanta, 

Georgia 30341, Telephone: (770) 488– 

3585, EEO6@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–03255 Filed 2–17–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention—State, Tribal, Local and 

Territorial (STLT) Subcommittee 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned subcommittee: 

Time and Date: 3:30 p.m.—5:00 p.m. 

EDT, March 13, 2015. 

Place: This meeting will be held by 

teleconference. 

Status: This meeting is open to the 

public, limited only by the availability 

of telephone ports. The public is 

welcome to participate during the 

public comment, which is tentatively 

scheduled from 4:45 p.m. to 4:55 p.m. 

To participate on the teleconference, 

please dial (888) 233–0592 and enter 

code 33288611. 

Purpose: The Subcommittee will 

provide advice to the CDC Director 

through the ACD on strategies and 

future needs and challenges faced by 

State, Tribal, Local and Territorial 

health agencies, and will provide 

guidance on opportunities for CDC. 

Matters for Discussion: The STLT 

Subcommittee members will discuss 

progress on implementation of ACDadopted recommendations related to 

Public Health Surveillance, Public 

Health Finance and Social Determinants 

of Health as they relate to STLT public 

health agencies. 

The agenda is subject to change as 

priorities dictate. 

Contact Person for More Information: 

Judith Monroe, M.D., Designated 

Federal Officer, State, Tribal, Local and 

Territorial Subcommittee, Advisory 

Committee to the Director, CDC, 1600 

Clifton Road NE., M/S E–70, Atlanta, 

Georgia 30333, Telephone (404) 498– 

0300, Email: OSTLTSDirector@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 


emcdonald on DSK67QTVN1PROD with NOTICES
8662 Federal Register / Vol. 80, No. 32 / Wednesday, February 18, 2015 / Notices 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. 2015–03252 Filed 2–17–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control; Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Establishing a Vision and Eye 

Health Surveillance System for the 

Nation, DP15–004, initial review. 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 10:00 a.m.–5:00 p.m., 

March 10, 2015 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in section 552b(c) 

(4) and (6), title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters for Discussion: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Establishing a Vision and Eye Health 

Surveillance System for the Nation, 

DP15–004, initial review.’’ 

Contact Person for More Information: 

M. Chris Langub, Ph.D., Scientific 

Review Officer, CDC, 4770 Buford 

Highway NE., Mailstop F–80, Atlanta, 

Georgia 30341, Telephone: (770) 488– 

3585, EEO6@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–03256 Filed 2–17–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity: Comment Request 

Title: ANA Reviewer Profile for Panel 

Review Participation Form. 

OMB No.: OMB No: 0970–265. 

Description: The Department of 

Health and Human Services (HHS), 

Administration for Children and 

Families (ACF) proposes to revise the 

ANA Reviewer Profile for Panel Review 

Participation Form. The ANA Reviewer 

Profile for Panel Review Participation 

Form is used to collect information from 

prospective proposal reviewers in 

compliance with 42 U.S.C. 2991d 1. 

First time reviewers will be required to 

complete all sections of the form while 

returning reviewers will be required to 

complete the first section of the 

document and other necessary updates. 

The form allows the Commissioner of 

ANA to select qualified people to 

review grant applications submitted in 

response to funding opportunity 

announcements for ANA’s primary 

programs: Social and Economic 

Development Strategies (SEDS); Native 

Language Preservation and 

Maintenance; and Environmental 

Regulatory Enhancement. The panel 

review process is a legislative mandate 

in the ANA grant funding process. 

Respondents: All US citizens 

including: Native Americans, Native 

Alaskans, Native Hawaiians and other 

Pacific Islanders. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

ANA Consultant and Evaluator Qualifications Form ....................................... 300 1 .5 150 

Estimated Total Annual Burden 

Hours: 150. 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 370 L’Enfant 

Promenade SW., Washington, DC 20447, 

Attn: ACF Reports Clearance Officer. 

Email address: infocollection@

acf.hhs.gov. All requests should be 

identified by the title of the information 

collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Robert Sargis, 

Report Clearance Officer. 

[FR Doc. 2015–03302 Filed 2–17–15; 8:45 am] 

BILLING CODE 4184–01–P 


emcdonald on DSK67QTVN1PROD with NOTICES